Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)

NCT06161116 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

149

Enrollment

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: MK-6194
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC